Effect of Controlled Hypotension on GFAP and Cognition in Rhinoplasty
Evaluation of the Effect of Controlled Hypotension During Elective Rhinoplasty on Serum Glial Fibrillary Acidic Protein (GFAP) and Cognitive Functions
1 other identifier
observational
40
0 countries
N/A
Brief Summary
This prospective observational study aims to evaluate the neurological safety of controlled hypotension (Mean Arterial Pressure 50-65 mmHg) during elective rhinoplasty. The investigators will assess whether this standard intraoperative hypotensive strategy causes cellular stress by measuring serum Glial Fibrillary Acidic Protein (GFAP) levels and early postoperative cognitive changes using the Montreal Cognitive Assessment (MoCA) test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2026
CompletedStudy Start
First participant enrolled
July 10, 2026
CompletedFirst Posted
Study publicly available on registry
July 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 30, 2027
July 14, 2026
July 1, 2026
8 months
July 7, 2026
July 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Serum Glial Fibrillary Acidic Protein (GFAP) Level
GFAP is a biomarker of astrocyte stress and blood-brain barrier permeability. Measured via ELISA (pg/mL).
Baseline (T0: Post-induction) and 24 hours postoperatively (T1).
Secondary Outcomes (2)
Change in Montreal Cognitive Assessment (MoCA) Score
Baseline (Preoperative ward visit) and 24 hours postoperatively.
Duration of Target Hypotension
Intraoperative period (from surgical incision to end of surgery, approximately 1-3 hours).
Study Arms (1)
Controlled Hypotension Cohort
Patients undergoing elective rhinoplasty receiving standard intraoperative controlled hypotension (Target MAP: 50-65 mmHg) maintained with sevoflurane and remifentanil.
Interventions
Maintenance of Mean Arterial Pressure (MAP) between 50 and 65 mmHg during the surgical procedure to optimize the surgical field.
Eligibility Criteria
The study population consists of adult patients, aged 18 to 50 years, who are scheduled to undergo elective primary rhinoplasty or septorhinoplasty under general anesthesia at the Department of Otorhinolaryngology and Plastic Surgery, Kahramanmaras Sutcu Imam University Hospital. Patients will be selected from those with an American Society of Anesthesiologists (ASA) physical status of I or II, ensuring a healthy cohort without severe systemic diseases.
You may qualify if:
- Scheduled for elective rhinoplasty or septorhinoplasty under general anesthesia.
- ASA physical status I or II.
- Literate and willing to provide written informed consent.
You may not qualify if:
- History of neurological (e.g., cerebrovascular event, epilepsy) or psychiatric diseases.
- Total septal reconstruction requiring costal (rib) cartilage grafts.
- Expected surgical duration exceeding 3 hours.
- Preoperative severe cognitive impairment.
- Pregnancy or lactation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cengizhan Yavuz, MD, Assistant Professor, Department of Anesthesiology and Reanimation
Study Record Dates
First Submitted
July 7, 2026
First Posted
July 13, 2026
Study Start
July 10, 2026
Primary Completion (Estimated)
February 28, 2027
Study Completion (Estimated)
March 30, 2027
Last Updated
July 14, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will become available beginning 6 months and ending 36 months following the publication of the primary research article.
- Access Criteria
- Data will be shared with researchers who provide a methodologically sound research proposal. Requests should be directed to the corresponding author via email. Requestors will be required to sign a data access agreement.
De-identified individual participant data (IPD) that underlie the results reported in the final publication will be shared upon reasonable request. Data will only be shared for academic, non-commercial purposes to ensure compliance with personal data protection regulations.